Chinese consumers, once the engine of growth for multinational companies, are cutting back on all kinds of things. Designer handbags, luxury face creams and trips to Paris have all fallen victim to ...

Guggenheim maintained a Buy rating on Merck (NYSE:MRK) shares but reduced the price target to $115 from $122. The adjustment follows a comprehensive review of the pharmaceutical giant's fourth-quarter ...

This commentary is a repost from "Sex on Wednesdays" by Martha Kempner on Substack. Find her other articles on The Queen... The post RFK Jr.'s HPV Vaccine Lawsuits: Who Really Stands to Profit?